Announced
Completed
Financials
Sources
Tags
Single Bidder
Friendly
Private
United States
Medical Supplies
innovative dental bone grafting
Acquisition
Domestic
Private Equity
Majority
Completed
Synopsis
Avista Capital-backed Solmetex, a manufacturer and supplier of amalgam separators and other waste compliance products, completed the acquisition of Impladent, a provider of a broad range of innovative and affordable regenerative materials including bone grafts and resorbable membranes used in tooth extraction procedures. Financial terms were not disclosed. "We are proud to partner with a leader and innovator in regenerative dental technology. We believe the addition of Impladent to our offering will unlock meaningful growth in new areas. I look forward to the opportunity to collaborate with the Impladent team and execute on our plans for future expansion." Gene Dorff, Solmetex Chief Executive Officer.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.